Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 419-050-3 | CAS number: 79944-37-9 AMINODIOXEPAN
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 1993 to August 1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 17 July 1992
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The test was conducted prior to implementation of the updated guideline. Furthermore, the test item showed a clear sensitizing potential, thus, potency is not required.
Test material
- Reference substance name:
- trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol
- EC Number:
- 419-050-3
- EC Name:
- trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol
- Cas Number:
- 79944-37-9
- Molecular formula:
- C7H15NO3
- IUPAC Name:
- 6-amino-2,2-dimethyl-1,3-dioxepan-5-ol
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Hagemann
- Weight at study initiation: 345-434 g males; 303-419 g females
- Housing: 1 or 2 in Makrolon® , type Ill cages; conventional
- Diet (e.g. ad libitum): ad libitum; pell. Altromin® MS, apple, hay
- Water (e.g. ad libitum): ad libitum; demineralized, acidified water (pH 2-3)
- Acclimation period: >18 days, maximization test; 7 days, local tolerance test
- Indication of any skin lesions: no
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-23
- Humidity (%): 54-70
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- paraffin oil
- Concentration / amount:
- 25%
- Day(s)/duration:
- 24h occlusive, then further 23 days (2 weeks after epdermal administartion)
- Adequacy of induction:
- non-irritant substance, but skin pre-treated with 10% SDS
- Route:
- intradermal
- Vehicle:
- paraffin oil
- Concentration / amount:
- 1.25%
- Day(s)/duration:
- 8 days
- Adequacy of induction:
- highest technically applicable concentration used
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- paraffin oil
- Concentration / amount:
- 25%
- Day(s)/duration:
- 24 h
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 10 males and 10 females
- Details on study design:
- RANGE FINDING TESTS:
intracutaneous tolerance
(The intracutaneous tolerance of the test item was tested at 3 different concentrations on 3 animals, each at different sites of the neck.
Concentrations:
A = 5.0% (w/v) test item
B = 2.5% (w/v) test item
C = 1.25% (w/v) test item
Epidermal tolerance
4 animals (2M, 2F) received two concentrations of ZK 38.199 under occlusive conditions
(24-hour exposure time) on the right and left side (one concentration/side) under the spine.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: Two:
1) lntradermal injections: ln the neck region (right to left side of the spine) of each animal an overall area of 4 x 6 cm was shorn (10M/10F). A total of 6 lntradermal injections, 3 on each side, were made according to the following scheme:
A. Test group
a) 0.1 mL FCA + vehicle (1+1)
b) 0.1 mL test item 1.25% (w/v)
c) 0.1 mL test item 2.5% (w/v) + FCA (1 +1) ≙ 1.25% (w/v) of the test item
Control group
a) 0.1 mL FCA + vehicle (1+1)
b) 0.1 mL vehicle
c) 0.1 mL FCA + vehicle (1+1)
- Exposure period: injected once and fiurther treatment after 8 days
- Site: back, beginning cranial and moving to caudal
- Frequency of applications: once
2) Epidermal application
In order to provoke the possible sensitizing effect of the test item the same area of skin (4x 6 cm) in which lntradermal injections were performed was reshaved on day 8 of the test and epidermally treated with approximately 1 mL sodium lauryl sulphate [10% (w/v)] in liquid paraffin. 24 hours later, on day 9, 0.2 ml of a 25% (w/v) suspension of the test item in liquid paraffin was spread over a 2 x 4 cm filter paper (Whatmann, no. SMM) for use in the test group, whereas for the control group only liquid paraffin was used. This filter paper was subsequently applied to the above-mentioned area pretreated with sodium lauryl sulphate. The patch was bandaged occlusively for 48 hours.
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 24 h at days 23
- Exposure period: 24 h
- Test groups: Approximately 0.1 mL test item [25% (w/v)] in liquid paraffin, which previously proved to be locally tolerated, was spread over a 2 x 2 cm piece of filter paper. This patch was placed in the middle of the shorn area of skin and bandaged occlusively for 24 hours. Reactions were recorded 24 and 48 hours after removal of the bandage.
- Control group: On day 23 (two weeks after the epidermal administration) a skin area of 5 x 5 cm was shorn on the right flank of each animal in both groups.
- Evaluation (hr after challenge): 24 and 48h
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- not reported
- Clinical observations:
- not reported
- Remarks on result:
- other: results not reported
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- not reported
- Clinical observations:
- not reported
- Remarks on result:
- other: results not reported
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 4
- Total no. in group:
- 10
- Clinical observations:
- One animal (no 8F) showed apathy, loss of body weight, prone position etc. after removal of the bandage after epidermal induction (day 11 of the test). The animal was sacrificed moribund on day 13 of the test.
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 4
- Total no. in group:
- 10
- Clinical observations:
- One animal (no 8F) showed apathy, loss of body weight, prone position etc. after removal of the bandage after epidermal induction (day 11 of the test). The animal was sacrificed moribund on day 13 of the test.
- Remarks on result:
- positive indication of skin sensitisation
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- In the present GPMT some clinical signs were observed. One animal (no 8F) showed apathy, loss of body weight, prone position etc. after removal of the bandage after epidermal induction (day 11 of the test). The animal was sacrificed moribund on day 13 of the test. Macroscopic findings after post-mortem examination, raised suspicion of pneumonia.
On the basis of the local results after the epidermal challenge, Aminodioxepan proved to have a sensitizing potential in the guinea-pig. - Executive summary:
In a dermal sensitization study similar to OECD test guideline 406 (GPMT) with Aminodioxepan (100% a.i) in paraffin oil, young adult Pirbright White guinea-pigs (10/sex) were tested using the method of Magnusson and Kligman. In a pretest the maximum tolerable (epidermal and intradermal) concentration of the test item in paraffin oil was determined as 25% and 1.25 %, respectively. For the intradermal induction three different injections (1.25%) were made along the spine from cranial to caudal.
For the epidermal induction 25% of the test item were applied to the dorsal site of the guinea pigs for 48h after pretreatment with 10% SDS in paraffin oil for 24h. Two weeks after epidermal induction the challenge procedure was performed with 25% of the test item spread on a filter paper and applied to the site where the induction took place. The site was bandaged occlusively for 24 h and thereafter the reactions were recorded after 24 and 48 h.
One animal (no 8F) showed apathy, loss of body weight, prone position etc. after removal of the bandage after epidermal induction (day 11 of the test). The animal was sacrificed moribund on day 13 of the test. Macroscopic findings after post-mortem examination, raised suspicion of pneumonia.
On the basis of the local results after the epidermal challenge, Aminodioxepan proved to have a sensitizing potential in the guinea-pig.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
